Cargando…

Residual gall bladder: An emerging disease after safe cholecystectomy

BACKGROUNDS/AIMS: Residual gallbladder mucosa left after subtotal/partial cholecystectomy is prone to develop recurrent lithiasis and become symptomatic, which mandates surgical removal. METHODS: We retrospectively evaluated the patients with residual gallbladder referred to us from January 2011 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Vikas, Sharma, Anil Kumar, Kumar, Pradeep, Gupta, Mantavya, Gulati, Ajay, Sinha, Saroj Kant, Kochhar, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Hepato-Biliary-Pancreatic Surgery 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893054/
https://www.ncbi.nlm.nih.gov/pubmed/31825001
http://dx.doi.org/10.14701/ahbps.2019.23.4.353
_version_ 1783476143183101952
author Gupta, Vikas
Sharma, Anil Kumar
Kumar, Pradeep
Gupta, Mantavya
Gulati, Ajay
Sinha, Saroj Kant
Kochhar, Rakesh
author_facet Gupta, Vikas
Sharma, Anil Kumar
Kumar, Pradeep
Gupta, Mantavya
Gulati, Ajay
Sinha, Saroj Kant
Kochhar, Rakesh
author_sort Gupta, Vikas
collection PubMed
description BACKGROUNDS/AIMS: Residual gallbladder mucosa left after subtotal/partial cholecystectomy is prone to develop recurrent lithiasis and become symptomatic, which mandates surgical removal. METHODS: We retrospectively evaluated the patients with residual gallbladder referred to us from January 2011 to December 2017. Based on MRCP we classified calot's anatomy to – type I where cystic duct was seen and type II where sessile GB stump was seen. RESULTS: 21 patients with median age 38 years and M:F::1:9.5, had undergone cholecystectomy (3 months-20 years) prior, presented with recurrent biliary pain. 3 had jaundice (CBD stone, Mirizzi and biliary stricture), 1 had pancreatitis and one had malignancy of the GB. Imaging revealed type I anatomy in 14 (67%) and type II in 7 (33%). All underwent completion cholecystectomy – open in 18 and laparoscopic in 3 (one converted to open). Additional procedure was required in 5 patients – CBD exploration in 2 (10%) and one each Hepatico-jejunostomy, extended cholecystectomy and splenectomy. Median hospital stay was 1 day. There was no mortality and 10% morbidity. One patient with malignancy died at 2 years, two died of unrelated cause, one developed incisional hernia and the remaining were well at a median follow up of 29 months. CONCLUSIONS: Residual GB lithiasis should be suspected if there are recurrent symptoms after cholecystectomy. MRCP based proposed classification can guide the management strategy. Completion cholecystectomy is curative.
format Online
Article
Text
id pubmed-6893054
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Association of Hepato-Biliary-Pancreatic Surgery
record_format MEDLINE/PubMed
spelling pubmed-68930542019-12-10 Residual gall bladder: An emerging disease after safe cholecystectomy Gupta, Vikas Sharma, Anil Kumar Kumar, Pradeep Gupta, Mantavya Gulati, Ajay Sinha, Saroj Kant Kochhar, Rakesh Ann Hepatobiliary Pancreat Surg Original Article BACKGROUNDS/AIMS: Residual gallbladder mucosa left after subtotal/partial cholecystectomy is prone to develop recurrent lithiasis and become symptomatic, which mandates surgical removal. METHODS: We retrospectively evaluated the patients with residual gallbladder referred to us from January 2011 to December 2017. Based on MRCP we classified calot's anatomy to – type I where cystic duct was seen and type II where sessile GB stump was seen. RESULTS: 21 patients with median age 38 years and M:F::1:9.5, had undergone cholecystectomy (3 months-20 years) prior, presented with recurrent biliary pain. 3 had jaundice (CBD stone, Mirizzi and biliary stricture), 1 had pancreatitis and one had malignancy of the GB. Imaging revealed type I anatomy in 14 (67%) and type II in 7 (33%). All underwent completion cholecystectomy – open in 18 and laparoscopic in 3 (one converted to open). Additional procedure was required in 5 patients – CBD exploration in 2 (10%) and one each Hepatico-jejunostomy, extended cholecystectomy and splenectomy. Median hospital stay was 1 day. There was no mortality and 10% morbidity. One patient with malignancy died at 2 years, two died of unrelated cause, one developed incisional hernia and the remaining were well at a median follow up of 29 months. CONCLUSIONS: Residual GB lithiasis should be suspected if there are recurrent symptoms after cholecystectomy. MRCP based proposed classification can guide the management strategy. Completion cholecystectomy is curative. Korean Association of Hepato-Biliary-Pancreatic Surgery 2019-11 2019-11-29 /pmc/articles/PMC6893054/ /pubmed/31825001 http://dx.doi.org/10.14701/ahbps.2019.23.4.353 Text en Copyright © 2019 by The Korean Association of Hepato-Biliary-Pancreatic Surgery http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gupta, Vikas
Sharma, Anil Kumar
Kumar, Pradeep
Gupta, Mantavya
Gulati, Ajay
Sinha, Saroj Kant
Kochhar, Rakesh
Residual gall bladder: An emerging disease after safe cholecystectomy
title Residual gall bladder: An emerging disease after safe cholecystectomy
title_full Residual gall bladder: An emerging disease after safe cholecystectomy
title_fullStr Residual gall bladder: An emerging disease after safe cholecystectomy
title_full_unstemmed Residual gall bladder: An emerging disease after safe cholecystectomy
title_short Residual gall bladder: An emerging disease after safe cholecystectomy
title_sort residual gall bladder: an emerging disease after safe cholecystectomy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893054/
https://www.ncbi.nlm.nih.gov/pubmed/31825001
http://dx.doi.org/10.14701/ahbps.2019.23.4.353
work_keys_str_mv AT guptavikas residualgallbladderanemergingdiseaseaftersafecholecystectomy
AT sharmaanilkumar residualgallbladderanemergingdiseaseaftersafecholecystectomy
AT kumarpradeep residualgallbladderanemergingdiseaseaftersafecholecystectomy
AT guptamantavya residualgallbladderanemergingdiseaseaftersafecholecystectomy
AT gulatiajay residualgallbladderanemergingdiseaseaftersafecholecystectomy
AT sinhasarojkant residualgallbladderanemergingdiseaseaftersafecholecystectomy
AT kochharrakesh residualgallbladderanemergingdiseaseaftersafecholecystectomy